skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Spermidine reverses arcaine's inhibition of N-methyl-D-aspartate-induced hippocampal ( sup 3 H)norepinephrine release

Abstract

The inhibition of N-methyl-D-aspartate (NMDA)-induced ({sup 3}H)norepinephrine (({sup 3}H)NE) release by a putrescine analog was studied. We report that arcaine, diguanidinobutane, a putative competitive polyamine antagonist, completely and noncompetitively antagonized NMDA-induced ({sup 3}H)NE release from rat hippocampal minces with an IC50 value of 102 microM. Arcaine did not alter kainate- or potassium-induced ({sup 3}H)NE release suggesting a specific effect on NMDA-mediated responses. Spermidine did not alter NMDA-induced ({sup 3}H)NE release, nor did it reverse the effect of arcaine when introduced in a normal physiologic superfusion buffer. However, spermidine reversed the effect of arcaine when superfusing with buffer that contained 5% (v/v) of the organic solvent dimethylsulfoxide. This finding suggests that the polyamine site may be located at the intracellular surface of the cell membrane. Our results provide the first evidence for polyamine modulation of the NMDA receptor ionophore complex in a functional physiologic system.

Authors:
;  [1]
  1. (Univ. of Texas Medical Branch, Galveston (USA))
Publication Date:
OSTI Identifier:
6152306
Resource Type:
Journal Article
Resource Relation:
Journal Name: Journal of Pharmacology and Experimental Therapeutics; (USA); Journal Volume: 255:3
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; ASPARTIC ACID; RECEPTORS; NORADRENALINE; SECRETION; PUTRESCINE; BIOCHEMICAL REACTION KINETICS; SPERMIDINE; CELL MEMBRANES; HIPPOCAMPUS; INHIBITION; RATS; TRACER TECHNIQUES; TRITIUM COMPOUNDS; ADRENAL HORMONES; AMINES; AMINO ACIDS; ANIMALS; AUTONOMIC NERVOUS SYSTEM AGENTS; BODY; BRAIN; CARBOXYLIC ACIDS; CARDIOTONICS; CARDIOVASCULAR AGENTS; CELL CONSTITUENTS; CENTRAL NERVOUS SYSTEM; DRUGS; HYDROGEN COMPOUNDS; ISOTOPE APPLICATIONS; KINETICS; MAMMALS; MEMBRANE PROTEINS; MEMBRANES; NERVOUS SYSTEM; NEUROREGULATORS; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANS; PROTEINS; REACTION KINETICS; RODENTS; SYMPATHOMIMETICS; VERTEBRATES; 550201* - Biochemistry- Tracer Techniques

Citation Formats

Sacaan, A.I., and Johnson, K.M.. Spermidine reverses arcaine's inhibition of N-methyl-D-aspartate-induced hippocampal ( sup 3 H)norepinephrine release. United States: N. p., 1990. Web.
Sacaan, A.I., & Johnson, K.M.. Spermidine reverses arcaine's inhibition of N-methyl-D-aspartate-induced hippocampal ( sup 3 H)norepinephrine release. United States.
Sacaan, A.I., and Johnson, K.M.. 1990. "Spermidine reverses arcaine's inhibition of N-methyl-D-aspartate-induced hippocampal ( sup 3 H)norepinephrine release". United States. doi:.
@article{osti_6152306,
title = {Spermidine reverses arcaine's inhibition of N-methyl-D-aspartate-induced hippocampal ( sup 3 H)norepinephrine release},
author = {Sacaan, A.I. and Johnson, K.M.},
abstractNote = {The inhibition of N-methyl-D-aspartate (NMDA)-induced ({sup 3}H)norepinephrine (({sup 3}H)NE) release by a putrescine analog was studied. We report that arcaine, diguanidinobutane, a putative competitive polyamine antagonist, completely and noncompetitively antagonized NMDA-induced ({sup 3}H)NE release from rat hippocampal minces with an IC50 value of 102 microM. Arcaine did not alter kainate- or potassium-induced ({sup 3}H)NE release suggesting a specific effect on NMDA-mediated responses. Spermidine did not alter NMDA-induced ({sup 3}H)NE release, nor did it reverse the effect of arcaine when introduced in a normal physiologic superfusion buffer. However, spermidine reversed the effect of arcaine when superfusing with buffer that contained 5% (v/v) of the organic solvent dimethylsulfoxide. This finding suggests that the polyamine site may be located at the intracellular surface of the cell membrane. Our results provide the first evidence for polyamine modulation of the NMDA receptor ionophore complex in a functional physiologic system.},
doi = {},
journal = {Journal of Pharmacology and Experimental Therapeutics; (USA)},
number = ,
volume = 255:3,
place = {United States},
year = 1990,
month =
}
  • Tetrodotoxin reduced N-methyl-D-aspartate (NMDA)-evoked release of adenosine by 35% but virtually abolished (3H)norepinephrine release. Although (3H)norepinephrine release from rat cortical slices evoked by 500 microM NMDA was abolished by 1.2 mM Mg++, which produces a voltage-sensitive, uncompetitive block of NMDA-channels, adenosine release was increased in the presence of Mg++. Partial depolarization with 12 mM K+ relieved the Mg++ block of 500 microM NMDA-evoked (3H)norepinephrine release but did not affect adenosine release, indicating that a Mg++ requirement for the adenosine release process per se cannot account for this discrepancy. NMDA was 33 times more potent in releasing adenosine than (3H)norepinephrine. Atmore » submaximal concentrations of NMDA (10 and 20 microM), adenosine release was augmented in Mg+(+)-free medium. Although a high concentration of the uncompetitive NMDA antagonist MK-801 ((+)-5-methyl-10,11,dihydro-5H-dibenzo(a,d)cyclohepten-5-10-imine maleate) (3 microM) blocked NMDA-evoked release of (3H)norepinephrine and adenosine, a lower concentration (300 nM) decreased NMDA-evoked (3H)norepinephrine release by 66% without affecting adenosine release. These findings suggest that maximal adenosine release occurs when relatively few NMDA receptors are activated, raising the possibility that spare receptors exist for NMDA-evoked adenosine release. Rather than acting as a protectant against excessive NMDA excitation, released adenosine might provide an inhibitory threshold which must be overcome for NMDA-mediated neurotransmission to proceed.« less
  • Long-term treatment with antidepressant agents alters the specific binding of /sup 3/H-clonidine, an alpha/sub 2/ adrenoreceptor agonist, to neural membranes isolated from specific areas of the rat brain. The purpose of the present study was to determine whether these changes in binding of /sup 3/H-clonidine represent an alteration in the functional state of the presynaptic alpha/sub 2/ adrenorecepotr. Hippocampal slices were incubated with /sup 3/H-norepinephrine (/sup 3/H-NE, 330 nM0 for 20 min, washed with fresh buffer for 30 min and then stimulated (4 Hz, 2 msec duration, 2 min) at 12 min intervals. Cumulative concentration-effect curves were determined of /supmore » 3/H-NE. Rats were injected, i.p., twice daily for 14 days with lithium chloride (105 mg/kg), desipramine HCl (10 mg/kg) or saline. In controls, the EC50 for clonidine was 2.3 +/- 1.0 nM (n = 3). After lithium treatment, the clonidine concentration-effect curve was shifted to the right, and the EC50 as 12.1 +/- 4.3 nM. Desipramine treatment nearly abolished the inhibitory effect of clonidine upon the release of /sup 3/H-NE by field stimulation. These observations indicate that the long-term administration of desipramine and lithium produce a functional subsensitivity of the alpha/sub 2/ adrenoreceptor which regulates norepinephrine release in the rat brain.« less
  • The phencyclidine (PCP) receptor acylator, metaphit, has been reported to act as a PCP antagonist. Recent electrophysiological and behavioral assessments of metaphit action have revealed, however, that this compound can also act as a PCP-like agonist. The present study examined the effects of metaphit on the inhibition of N-methyl-D-aspartate (NMDA)-induced /sup 3/H-acetylcholine (ACh) release, /sup 3/H-TCP binding and synaptosomal /sup 3/H-dopamine (DA) uptake in the rat striatum. Preincubation of striatal slices for 10 min in the presence of metaphit, followed by a prolonged washout, produced a concentration-dependent inhibition of the ACh release evoked by 300 ..mu..M NMDA. At high concentrations,more » preincubation with PCP also resulted in inhibition of this measure. However, this could be reduced by extending the washout period, a procedure which had no effect on the inhibition produced by metaphit. At 10..mu..M, metaphit resulted in a 53% reduction in NMDA-evoked ACh release while PCP had no effect under identical conditions. Preincubation of slices in 10 ..mu..M PCP and metaphit reduced the metaphit inhibition by 62%. The effects of PCP and metaphit, alone or in combination, on NMDA-induced ACh release were paralleled by a loss of /sup 3/H-TCP binding sites in striatal tissue incubated under identical conditions suggesting that metaphit exerts long-lasting agonist-like actions on PCP receptors coupled to NMDA receptors. 27 references, 3 figures, 1 table.« less
  • Organophosphorus (OP) compounds, used as insecticides and chemical warfare agents, are potent neurotoxins. We examined the neurotoxic effect of paraoxon (O,O-diethyl O-p-nitrophenyl phosphate), an organophosphate compound, and the role of NMDA receptors as a mechanism of action in cultured cerebellar granule cells. Paraoxon is neurotoxic to cultured rat cerebellar granule cells in a time- and concentration-dependent manner. Cerebellar granule cells are less sensitive to the neurotoxic effects of paraoxon on day in vitro (DIV) 4 than neurons treated on DIV 8. Surprisingly, the N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801, enhances paraoxon-mediated neurotoxicity suggesting that NMDA receptors may play a protective role.more » Pretreatment with a subtoxic concentration of N-methyl-D-aspartate (NMDA) [100 {mu}M] protects about 40% of the vulnerable neurons that would otherwise die from paraoxon-induced neurotoxicity. Moreover, addition of a neuroprotective concentration of NMDA 3 h after treatment with paraoxon provides the same level of protection. Because paraoxon-mediated neuronal cell death is time-dependent, we hypothesized that apoptosis may be involved. Paraoxon increases apoptosis about 10-fold compared to basal levels. The broad-spectrum caspase inhibitor (Boc-D-FMK) and the caspase-9-specific inhibitor (Z-LEHD-FMK) protect against paraoxon-mediated apoptosis, paraoxon-stimulated caspase-3 activity and neuronal cell death. MK-801 increases, whereas NMDA blocks paraoxon-induced apoptosis and paraoxon-stimulated caspase-3 activity. These results suggest that activation of NMDA receptors protect neurons against paraoxon-induced neurotoxicity by blocking apoptosis initiated by paraoxon.« less
  • The effect of two different potassium channel blockers, 4-aminopyridine (4-AP) and quinine, on the alpha 2-adrenoceptor mediated modulation of norepinephrine (NE) release was investigated. Pairs of mouse vasa deferentia were loaded with /sup 3/H-norepinephrine (/sup 3/H-NE), superfused continuously, and stimulated electrically. 4-AP (5.3 x 10(-4) M), and quinine (10(-5) M) enhanced the stimulation-evoked release of tritium significantly. The electrically induced release of radioactivity was reduced by alpha 2-adrenoceptor agonists (1-NE and xylazine) and enhanced by the alpha 2-adrenoceptor antagonist yohimbine. Both effects were affected markedly by 4-AP or quinine: the depressant action of 1-NA and xylazine was partially antagonized andmore » the facilitatory effect of yohimbine was completely abolished during the blockade of the potassium channels. It is suggested that the blockade of the potassium permeability counteracts negative feedback modulation; therefore, it seems likely that the stimulation of alpha 2-adrenoceptors leads to an enhanced potassium permeability and hyperpolarization of varicose axon terminals.« less